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Summary 
 
Singapore grouper iridovirus (SGIV) is a major pathogen that causes significant economic losses 
in marine farms specially in Singapore and South East Asia.  
 
The virus contains a dsDNA genome of about 140kb predicted to encode 162 open reading 
frames(ORFs). Our previous proteomics and transcriptomics study had identified ORF86R as an 
immediately early (IE) gene. We hypothesize that ORF086R may play an important role in virus 
infection and replication. Both full length and truncated ORF086R were cloned and expressed in E. 
coli to get soluble and stable protein for raising antibody and crystal screening. Gene knock-down 
platform using morpholino antisense oligonucleotides (MO) was successfully set up in our lab. 
Antisense morpholino oligonucleotide (asMOs) was used to knock down ORF86R expression in 
grouper embryonic cells. TCID50 and electron microscope were carried out to examine the viral 
infectivity and replication. We observed that TCID50 was not reduced and viral morphology was 
not affected after the gene knockdown. For the functional study, ORF086R may not play important 
role in virus replication and assembly. Circular dichroism (CD) and dynamic light scattering (DLS) 
also showed that the protein is likely to be folded. The protein is mainly composed of β-sheet 
structures by secondary structure prediction. Ongoing experiments are focused on identification of 
ORF086R’s binding partners and optimization of its crystallization conditions, which may help us 
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1.1 Introduction to virus 
 
 A virus is a biological agent that reproduces inside the cells of living hosts. Most viruses 
are too small to be seen directly with a light microscope. Viruses infect almost all types 
of organisms. After Martinus Beijerinck initially discovered the tobacco mosaic virus in 
1898, over 2,000 species of viruses have been found. A host cell is forced to produce 
many thousands of identical copies of the original virus once infected. New viruses are 
assembled in the infected host cells and later secreted. 
 
Viruses are composed of protein coats (virus capsids) and genomic contents. The 
genomic contents inside of the virus could be either DNA or RNA.  Virues can be 
classified into two major groups, DNA viruses and RNA viruses. DNA viruses contain 
both single-stranded DNA (ssDNA) viruses and double-stranded DNA (dsDNA) viruses. 
The dsDNA viruses have more than 20 families. 
 
 
1.2 Introduction to Iridovirus 
 
The family Iridoviridae (i.e. the iridoviruses family) is a member of the DNA virus 
families. It consists of large cytoplasmic DNA viruses that infect insects and cold-
blooded vertebrates.  Smith and Xeros discovered the first iridovirus in 1954. More than  
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100 iridoviruses have been isolated now. There are five genera: Iridovirus, 
Chloriridovirus, Lymphocystivirus, Megalocytivirus and Ranavirus (Williams et al.,  
2006). They have icosahedral symmetry. The virion is made up of three parts; an outer 
capsid, an intermediate lipid membrane, and a central core containing DNA-protein 
complexes. Some of the viruses also have an outer envelope. 
 
Iridoviruses are icosahedral viruses with 120 to 300 nm in diameter. The genome of 
iridoviruses is between 100 and 210 kbp and composed of double-stranded linear DNA. 
The two genera-Ranavirus and Lymphocystivirus only infect cold blooded animals, such 
as fish, amphibians, and reptiles while the genus-Megalocytivirus only infects marine fish 
in South East Asia(Chinchar et al., 2008). However, several isolates have not been 
characterized to a sufficient level to be assigned to any genus.  Several species under the 












Table 1.1 Current classification of the Family Iridoviridae 
    Tipula paluosa IV 
  Iridovirus Sericesthis pruinosa IV 
    Chilo suppessalis IV 
  Choriridovirus Acdes taeniorhynchus IV 
    Acedes cantans IV 
    Frog virus 3 
    Frog virus 1, 2, 5-24 
  Ranavirus Singapore grouper iridovirus 
Iridoviridae   Ambystoma tigrinum virus 
    Tiger frog virus 
    Lymphocystis disease virus type 1 
 Lymphocystivirus 2Lymphocystis disease virus type c 
    Octopus vulgaris disease virus 
    Red Sea bream iridovirus 
  Megaloctivirus Taiwan grouper iridovirus 
    Olive flounder iridovirus 
    Rock bream iridovirus 
  Unassigned White sturgeon iridovirus 




 1.3 Replication cycle of iridovirus 
 
It is reported that the iridovirus replication mainly comes from the study of FV-3 (Figure 
1.1). The virus particle binds to a currently unknown cellular receptor of host cells 
(Chinchar et al., 2008). After binding, enveloped virus enter into cell via receptor 
mediated endocytosis. After entry, virion is uncoated to release the central protein/DNA 
core . The protein/DNA complex core makes its way into the nucleus. Early viral gene 
transcription and first phase DNA synthesis are two major events in the nucleus at the 
early stage infection (Williams et al., 2006). Newly synthesized viral DNA is exported 
out of the nucleus into the cytoplasm (Goorha, 1982), where further DNA replications 
take place. Large concatameric DNA structures are formed through recombination 
between unit viral genome, which represents second phase DNA replication (Goorha and 
Dixit, 1984). Late stage gene transcription is also carried out in cytoplasm. The DNA and 
late viral transcripts encoded viral proteins enter cytoplasmic virion assembly site (VAS), 
where viral DNA and proteins assemble into mature virions. The mature viruses form in 
to paracrystalline array. Some of them are released through viron budding, most of the 
mature viruses came out with cells released. 
 
Until now, in vertebrate iridovirus, SGIV is the only one that lacks a DNA 
methyltransferase which suggested that methylation is not an essential step for viral 
infection (Song et al., 2004). Events in virus replication are summarized in Figure 1.1 









Figure 1.1 Iridovirdae replication cycle. The life cycle of frog virus 3 (FV3) is illustrated. 







 1.4 Introduction and Research Progress of Singapore Grouper 
Iridovirus (SGIV) 
 
1.4.1 Introduction of SGIV 
It is reported that a novel member of Ranavirus, Singapore grouper iridovirus (SGIV), 
caused significant economic losses in Singapore marine net cage farm in 1994 (Chua et 
al., 1994). It causes “Sleepy Grouper Disease” (SGD) in grouper fish (Chua et al., 1994, 
Qin et al., 2001, Song et al., 2004). SGIV was isolated from brown groupers in 1998 (Qin 
et al., 2001). The genomic DNA of SGIV was sequenced in 2004 (Song et al., 2004). 
SGIV genome is 140,131 nucleotide bp long, with 17 repetitive regions covering 2.6% of 
SGIV genome and is also circularly permuted and terminally redundant. Totally, 162 
presumptive open reading frames (ORF) have been annotated from sense and antisense 
strand of SGIV genome (Song et al., 2004). Among them, 24 proteins have been 
identified with significant homology to known proteins, another 66 with sequence 
similarities with unknown proteins of Iridovirdae family or have a relative low homology 
with known proteins, the remaining 72 putative proteins have no significant homology in 
the current database (Song et al., 2004). Previously our lab has identified several SGIV 
structural proteins with different proteomics methods (1D SDS-PAGE MALDI TOF 
PMF approach, 1D SDS-PAGE MALDI-TOF MS/MS approach, LC-MALDI shotgun 




 For the first two methods, the purified SGIV virions were treated with SDS-loading dye 
and resolved with 1D SDS-PAGE, the protein bands were incised from gel and analyzed 
with mass spectrometry. For PMF approach, only peptide information was captured by 
MS machine and for MS/MS approach, the peptides with high signal intensity were 
further analyzed and its amino acid sequence was further identified. For the third method, 
purified virions were treated with sonication and the peptide mixtures from purified 
virion were separated with a liquid chromatography. The different peptide fractions were 
analyzed by MALDI-TOF MS/MS. For the last method, iTRAQ is a proteomic method 
which is sensitive and can detect small amount of proteins. Uninfected cells and infected 
cells were treated with lysis buffer, quantitatively analysis with iTRAQ machine on the 
same amount of total proteins. It can analyze the protein amount in parallel, which may 
suggest protein interactions.  
 
Up to date, seventy-two proteins were identified by the four approaches and among them 
seventeen proteins were confirmed by all MS approaches which suggested that they are 
abundant structural proteins. (Song et al., 2004, Song et al., 2006).  
 
 
1.4.2 Structure of SGIV  
Sucrose gradient ultracentrifugation has been developed for the purification of SGIV 
(Qin et al., 2003). Most of the virus was suspended at the boundary layer between 40% 
and 50% sucrose (an equilibrium density banding) with this approach. The virus was 
negative stained and examined under electron microscopy. The viral particle revealed a 
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 three-layer membrane structure with an inner electron-dense core. The average size of 
SGIV was also determined by electron microscopy and  was estimated as 200±13nm. The 
SGIV formed a well-defined hexagonal contour, suggesting that the three-dimensional 
structure of the SGIV is an icosahedral particle (Qin et al., 2001). SGIV particle is 
showed in Figure 1.2. 
 
 
                                                   
 
Figure 1.2 SGIV single particle is observed under electron microscopy. It is a well-
defined hexagonal contour (Qin et al., 2001). 
 
 
1.4.3 Physical properties of SGIV  
One important aspect of the SGIV is its physicochemical properties (Qin et al., 2001). 
The infectivity of the SGIV isolate maintained at a high titer of 106.0 TCID50 ml-1, 
propagated continuously in a grouper embryonic cell line. Nevertheless, the infectivity 
dropped dramatically when treated by high temperature at 56 ºC for 30 min. Under an 
acidic environment with 0.1 M citrate buffer (pH 3.0), the SGIV almost lost all its 
infectivity in culture media. Through the two method treatment, the titer was reduced 
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 dramatically from 107.0 to 103.0 TCID50 ml-1. The SGIV was affected with low 
concentration of 5-iodo-2-deoxyuridine treatment (IUdR, 10 µM), suggesting that the 
virus possessed a DNA genome. Elucidation of physicochemical properties of the SGIV 
has facilitated us to monitor the fish disease. Besides, all the above characteristics 
provide the evidence for the classification of SGIV within the virus kingdom. However, 




1.4.4 Temporal and differential stage gene expression of SGIV 
A DNA microarray was generated for the SGIV genome to analyze the expression of its 
predicted ORFs. At different time point, the noninfected and infected cells of SGIV 
infection were collected and treated with cycloheximide and aphidicoline to study the 
temporal stage of gene expression (such as Immediate Early, Early and Late genes).  A 
translation inhibitor, Cytoheximide, blocked DE/L genes transcription but not IE genes 
transcription. A DNA replication inhibitor, Aphidicoline, blocked L genes transcription 
but not IE/DE genes transcription (Chen et al., 2006). The DNA microarray data was 
verified with real-time RT-PCR studies (Chen et al., 2006).  
  
A microarray study showed that the gene transcription of SGIV is in a temporal sequence 
which can be clustered into three coordinated phases: (1) immediate early (IE): 28 ORFs; 
(2) delayed early/early (DE/E): 49 ORFs; (3) late (L): 37 ORFs (Chen et al., 2006). 114 
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 of all 162 predicated ORFs were classified and the rest could not be classified. These 
results provide important insights into the replication and pathogenesis of iridoriviruse. 
 
 
1.5 Introduction to Morpholino oligonucleotides technology 
 
1.5.1 Gene knock-down 
Gene knock-down is a technique in which an organism is genetically modified to reduce 
the expression of one or more genes through the insertion of an agent such as a short 
DNA or RNA olionucleotide with a sequence complementary to an active gene or its  
mRNA transcripts (Summerton, 2007). 
There are three major gene knock-down types: 1) phosphorothiotate-linked DNA(S-
DNA); 2) short interfering RNA (siRNA); 3) Morpholino. The structure of these 3 types 
of gene knock-down are illustrated in Table 1.2 (Summerton, 2007). 
 
 
1.5.2 Gene knock down by Morpholino 
1.5.2.1 Morpholino 
Morpholinos or morpholino antisense oligonucleotides or oligos are called MO in short 
form. MO is a gene knock-down agent which consists of short chains of about 25 
morpholino subunits. Each morpholino subunit contains a nucleotide base, a morpholine 

















1.5.2.2 Mechanism of MO gene knock down 
Morpholinos act via a steric blockage mechanism (RNAse H-independent) and with high 
mRNA binding affinity and specificity, yield reliable and predictable results. They can 
either block translation initiation in the cytosol, modify pre-mRNA splicing in the 
nucleus or block miRNA activity (Summerton, 2007). 
 
 
1.6 Introduction to NMR spectroscopy  
 
In 1946, Purcell and Bloch reported for the first time the nuclear magnetic resonance 
(NMR) phenomenon (Filler, 2009). In 1953, Overhauser defined the concept of nuclear 
overhauser effect (NOEs), which formed the basis for the structural determination by 
NMR (J. Keeler, 2005). After three decades, the first protein structure was solved using 
NMR spectroscopy by Ernst and Wuthrich. Since then, NMR spectroscopy has become 
an alternative method to X-ray crystallography for the structural determination of small to 
medium sized proteins in aqueous or micellar solutions. Recent progress in computational 
and experimental NMR techniques has improved the efficiency of biological research (J. 
Keeler, 2005). 
 
A simple one-dimensional (1D) proton experiment is the most basic spectrum in NMR 
spectroscopy that contains a vast amount of information. It is able to show the folding 
status of the proteins. This is very important for any further functional or structural 
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 studies on the protein because only folded proteins retain their three dimensional 
structure and functional activities. Unfortunately, 1D spectrum of protein molecules that 
contain overlapping signals from many hydrogen atoms due to the differences in 
chemical shifts are often smaller than the resolving power of the experiments. 
 
To further resolve the structure of protein, two-dimensional and three-dimensional 
experiments would greatly improve in structure resolution. Protein was labeled by N15 in 
2D experiment while protein was labeled both N15 and C13 in 3D experiment. 
 
 
1.7 Introduction of circular dichroism  
 
Circular dichroism (CD) spectroscopy measures differences in the absorption of left-
handed polarized light versus right-handed polarized light which arise due to structural 
asymmetry. The absence of regular structure results in zero CD intensity, while an 
ordered structure results in a spectrum which can contain both positive and negative 
signals. CD spectroscopy has a wide range of applications in many different fields 
(Whitmore L, Wallace BA, 2008). 
 
Secondary structure can be determined by CD spectroscopy in the "far-UV" spectral 
region (190-250 nm). At these wavelengths the chromophore are the peptide bond, and 
the signal arises when it is located in a regular, folded environment. Alpha-helix, beta-
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 sheet, and random coil structures each give rise to a characteristic shape and magnitude 
of CD spectrum (Figure1.3).  
 
 
Figure 1.3 CD spectroscopy of protein secondary structure (John Philo, 2003) 
 
 
1.8 Introduction of dynamic light scattering 
 
Dynamic Light Scattering is also known as Photon Correlation Spectroscopy. This 
technique is one of the most popular methods used to determine the size of particles. 
Shining a monochromatic light beam, such as a laser, onto a solution with spherical 
particles in Brownian motion causes a Doppler Shift when the light hits the moving 
particle, changing the wavelength of the incoming light. This change is related to the size 
of the particle. It is possible to compute the sphere size distribution and give a description 
of the particle’s motion in the medium, measuring the diffusion coefficient of the particle 
and using the autocorrelation function (Chu, B. 1992). 
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 This method has several advantages: first of all the experiment duration is short and it is 
almost all automatized so that for routine measurements an extensive experience is not 
required. Moreover, with this technique it is also possible to obtain absolute 
measurements of several parameters of interest, like molecular weight, radius of gyration, 
Translational diffusion constant and so on. However, the analysis might be difficult for 
non-rigid macromolecules (Chu, B. 1992).  
 
 
1.9 Objectives and significance of this project 
The characterization of viral proteins, especially the IE gene proteins, is of significant 
importance to study the mechanism of its infection and the assembly process of mature 
virus. Due to the availability of cell line, we have decided to take a functional and 
structural study of SGIV. The objectives of this project are: 
 
1) To discover the functions of novel SGIV genes. Among the 72 identified viral 
proteins, ORF086R is an IE gene protein, which is homologous with other iridovirus 
family members with novel function. Knock down platform was used in this study, 
the protein would be knocked down with antisense morpholino. Transmission 
Electron Microscope was used for observing the virus structure. 
 
2) To solve the three dimensional structure of selected viral proteins. ORF086R is a 
predicted structural protein with small molecular weight which could be solved with 






















 2.1 Molecular biology techniques (DNA related) 
 
2.1.1 PCR  
A total of 200 – 300 ng of template DNA/cDNA was incubated with a PCR mix with 0.5 
μl of each of the corresponding forward and reverse primers, 0.5 μl dNTPs, and 0.5 μl of 
DNA polymerase enzyme in 5 μl 10X PCR buffer made up with sterile ddH20 to a final 
volume of 50 μl. The PCR reaction was then performed by a thermal cycler under the 
program of three steps: (i) 94 °C for 5 min; (ii) 30 cycles of 95 °C for 30 sec, 60 °C for 
30 sec and 72 °C for 60 sec; (iii) 72 °C for 8 min. The parameters are needed to be 
optimized to overcome nonspecific or unsuccessful reactions.  
 
ORF086R primers of pGEX 6p-1 and pET28a-sumo are the same: 
Primer F: 5’-TAG GAT CCA TGG CCA TTC AAC TGA CAC T-3’ 
Primer R: 5’-ATA CTC GAG TTA AAC CCC TTG GAT GGT-3’ 
 
ORF086R primers of pET28b: 
Primer F: 5’-TAG GAT CCA TGG CCA TTC AAC TGA CAC T-3’ 
Primer R: 5’- TAC TCG AGA ACC CCT TGG ATG GTA AAT T-3’ 
 
2.1.2 Agarose gel electrophoresis  
The amplified PCR products were analyzed by agarose gel electrophoresis (0.8-1.5 % 




 2.1.3 PCR products purification  
Desired PCR amplified products were purified with QIAquickTM PCR purification kit 
following the manufacturer’s instructions.  
 
2.1.4 Enzyme digestion, dephosphorylation and purification  
10 μl of PCR products or a vector were incubated with 1 μl of restriction enzymes in 1X 
BSA solution and 1X reaction buffer, made to a total volume of 50 μl with sterile ddH20 
and incubated at 37 °C for 1-2 hours. The restriction digested vectors were then 
dephosphorylated by treating with 5 units of calf intestinal phosphatase at 37 °C for 1 
hour. All reactions were terminated by incubation at 85 °C for 20 min. Desired digested 
products were then excised from the agarose gel and purified using QIAquick gel 
extraction kit following the manufacturer’s instructions.  
 
2.1.5 Ligation and transformation  
The mixture of PCR products and the dephosphorylated vector at a ratio of 1:3 was 
incubated with 0.5 μl of T4 DNA ligase (400U/μl) and 1X reaction buffer, made to a total 
volume of 20 μl with sterile ddH20 at 16 °C overnight. The ligation products were ready 
to be transformed into the competent cell DH5α.  
100 μl competent cells were thawed on ice before the ligation product was added. The 
cells were kept on ice for 30 min. After heat shock at 42 °C for 60 sec, the cells were kept 
on ice for an additional 2 minutes. 800μl LB medium (antibiotic free) was added to the 
cells and mixed by gently inverting up and down. The cells were then incubated at 37 °C 
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 for 1 hour before plating onto LB agar plate (with antibiotic). The plates were incubated 
at 37 ºC until colonies shown.  
 
2.1.6 Positive clone screening and plasmid preparation  
Clones were picked up and inoculated in 3 ml LB medium with antibiotic at 37 ºC for 
O/N. PCR as well as double enzyme digestion were carried out. The products were 
separated on a 1.0 % agarose gel. The positive clones were selected for plasmid 
preparation using QIAprep spin miniprep kit following the manufacturer’s instructions. 
 
2.1.7 Cycle sequencing reaction 
Cycle sequencing was performed based on the standard protocol supplied by Applied 
Biosystems with minor modifications. The concentration of all the plasmid was 
determined. Each cycle sequencing reaction was composed of 2 μl of Terminator Ready 
Reaction Mix (BigDye™ v3.1), 3 μl of 5 x sequencing buffer, 3.2 pmol of primer, and 
300-400 ng recombinant plasmids with inserted viral DNA fragment to give a final 
volume of 20 μl. The entire reaction was subjected to 27 cycles of 96ºC for 30 s, 50ºC for 
15 s, and 60ºC for 4 min in a thermal cycler. The products of the cycle sequencing were 
transferred to a 1.5 ml eppendorf tube and precipitated for 15 min with 80 μl of 
ethanol/sodium acetate solution. The supernatant was carefully removed after 20 min of 
centrifugation at the maximal speed. To remove any trace of unincorporated dye, the 
DNA pellet was washed with 500 μl of 70 % alcohol. After standing for 15 min, the 
contents of the tube were spun down at 13,000 rpm for 5 min. After the supernatant was 
decanted, the tube was inverted and dried overnight at room temperature. 
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2.1.8 Sequence determination 
Each cycle sequencing product was dissolved in 12 μl Hi-Di formamide and mixed with 
brief vortexing. The tubes containing dissolved DNA fragments were transferred to a 96-
well sample plate or a PCR plate and covered with a piece of transparent stick tape. After 
heated at 95 ºC for 2 min, the plate was placed into a 96-well rack and quickly 
centrifuged to ensure that the samples were positioned correctly at the bottom of the wells. 
Prior to sequencing, the plate was placed on ice or 4 °C. The sequencing was carried with 
ABI PRISMTM 3100 Genetic Analyzer (supported by DBS DNA sequencing lab).  
 
2.1.9 Transformation  
The sequence verified plasmids were transformed into BL21 star cells (DE3) using the 
protocol described previously for protein expression.  
 
2.2 Protein techniques  
Proteins used in this study were all expressed using the E. coli system.  
 
2.2.1 Small scale test  
A small scale test for protein expression is to identify the optimal condition for protein 
production. 5 ml LB (2X YT) containing antibiotic was inoculated with a fresh single 
bacterial colony and incubated overnight at 37 °C with vigorous shaking (200 rpm) in a 
50 ml sterile tube. Pre-warmed 50 ml LB (2X YT) medium in 250-500 ml flask was 
inoculated with 1 ml of the overnight culture, supplemented with appropriate antibiotic, 
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 and incubated at 37 °C with shaking (180 rpm) until the OD600 reached 0.5 to 0.8 values. 
Induction by IPTG with 1 mM final concentration was usually used. The cells were then 
grown for another 2-6 hrs or overnight depending on the temperature (15-37 °C). 1 ml of 
the sample was then taken at regular intervals; the cells were pelleted and lysed by 
sonication, separated on a SDS-PAGE gel and visualized by Coomasie Blue staining to 
examine the levels of protein induction. 
 
2.2.2 Large scale production of recombinant protein  
Once the conditions were optimized for protein expression, large-scale production of 
recombinant proteins from E. coli was carried out by culturing cells at the previously 
optimized conditions. 50 ml LB (2X YT) enriched media were inoculated with a fresh 
single bacterial colony and incubated overnight at 37 °C with shaking (200 rpm) in a 100 
ml flask. For minimal medium, 50 μl culture grown in LB (2X YT) media was used as 
seeds, instead of a single bacterial colony. 10-15 ml of the overnight culture wa used to 
inoculate 1 L flasks with the desired medium containing an appropriate antibiotic, which 
was then incubated at 37 °C with shaking (180 rpm) until the OD600 reached 0.5 to 0.8 
values (OD was measured using a spectrophotometer). Once cells reached the desired OD 
they were induced with up to 0.3mM IPTG (final concentration). Cells were harvested 
overnight post-induction and purified immediately or frozen at -80 °C until further use.  
 
2.2.3 Cells lysis 
The harvested cells were resuspended with ice-cold lysis buffer Z (1L cells for 50ml 
buffer Z), the suspended cells were disrupt by sonicator for 20~30 minutes (1s on, 1 s off), 
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 during this step, it was stored on ice to keep the temperature from rising. After sonication, 
the well lysised bacterial cells were centrifuged at16000~18000rpm for at least 30 
minutes at 4oC. Carefully transfer the supernatant to a fresh tube or bottle and keep on ice.  
 
2.2.4 His column purification 
After cell lysis, apply the supernatant to 5ml His trap column on CU-960 (AKTA). After 
binding, wash His column with equilibrium buffer for 10-15CV (column volume) until 
the base line became smooth. Then, the protein was eluted by elution buffer at different 
concentration of imidazole depending on protein binding ability. The eluted proteins were 
determined by SDS-PAGE.  
 
2.2.5 Ion exchange purification 
Ion exchange purification separates proteins according to the protein charge, For instance, 
if a protein has a net negative charge at pH 7, then it will bind to a column of positively-
charged beads, whereas a positively charged protein would not. In this study, SP column 
was a column of negatively-charged beads. After the proteins bind to this column, the 
bound proteins can be eluted by changing the ionic strength of elution buffer (gradient 
change of NaCl from 10mM to1M). 
 
2.2.6 Size exclusion chromatography  
Size exclusion chromatography (SEC) or Gel filtration chromatography (GFC) separates 
proteins based on their size. Molecules move through a bed of porous beads. Smaller 
molecules diffuse further into the pores of the beads and therefore move through the bed  
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 more slowly, while larger molecules enter less or not at all and thus move through the 
bed more quickly. It may be used for analysis of molecular size, for separations of 
components in a mixture, or for salt removal or buffer exchange from a preparation of 
macromolecules (Rajni et.al, 2003). 
 
2.2.7 Twenty-five crystal screening kits 
Crystal screen 1, Crystal screen 2, quick screen, CryoScreen, Index, AsMax, NaMax, 
PhosMax, MemMax, Natrix, pH clear suite, pH clear suiteII, Mb class suite, Mb class 
suite II, MpdMax, PACT suite, CryoMax, Grid PEG6000, Protein complex suite, JCSG 
suite, Grid Screen Ammoinio Sulfate, Nucleix suite, ComPAS, Grid Screen NaCl, Anions. 
 
2.2.8 SDS-PAGE  
SDS polyacrylamide gel electrophoresis (SDS-PAGE) was performed. Discontinuous 
SDS-PAGE with a stacking gel (pH 6.8, 0.125 M Tris-HCl, 0.1 % SDS and 5 % 
acrylamide/Bis solution) and a resolving gel (pH 8.8, 0.375 M Tris-HCl, 0.1 % SDS and 
15 % acrylamide/Bis solution) was performed in 1X SDS running buffer (20 mM Tris 
Base, 200 mM glycine, 0.1 % SDS) at 70 volts for 30 min followed by 200 volts for 30-
60 min. After electrophoresis, the gel was stained in the Coomassie staining solution (45 
% methanol, 10 % acetic acid and 0.25 % Coomassie Brilliant Blue R-250) for 30-60 min, 





 2.2.9 Production of polyclonal antibodies  
To produce specific antibodies against any protein, normally, 5 mg of protein will be 
injected to a 2kg-rabbit for five times with two weeks interval in two months.  
 
2.3 Knock down platform methods 
 
2.3.1 Grouper embryonic cell line (GE cell line) and subculture 
The cell line used in this study is grouper embryonic cells from the brown-spotted 
grouper (Epinephelus tauvina) (Qin et.al, 2001) 
This cell lines was cultured in Eagles’ minimal essential medium (MEM), 10% heat-
inactivated fetal bovine serum (FBS), and 0.27% sodium chloride. 100IU/ml of penicillin 
G and 100 μl of streptomycin sulfate were added to prevent the contamination from 
bacteria and fungi. Culture media were equilibrated with HEPES to the final 
concentration of 5mM and adjust to pH 7.4 with sodium bicarbonate. 
For a 75-cm2  flask, the culture medium was removed once the grouper cell line achieved 
confluence. The cell confluent monolayers were rinsed by 1x phosphate buffered saline 
(PBS) followed by treatment with 1 ml of trypsin-EDTA (GIBCO) for 5 min. The 
grouper embryonic cells were gently suspended. Appropriate volume of the culture media 
was added to terminate the digestion. Cells were separated into different flasks with fresh 
media at 27oC incubator. 
 
2.3.2 AsMO Design and Transfection 
Antisense morpholino (asMO) design was based on the full sequenced genome 
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 and predicted ORFs (Song et al., 2004). Designed asMO and negative-control asMO 
(stander control oligo) are from GeneTools. AsMOs were delivered with Nucleofactor® 
kit (Amaxa) at 20 μM (Table2.1).  
 
Unlike DNA and RNA, which carries negative charge in biological system, morpholino 
carries no charge. In order to deliver asMO into the GE Cells with high efficiency, 
nucleofactor technology was applied. First the transfection efficiency was optimized with 
protocols and pmaxGFPTM provided from Amaxa. The optimized program was T-27 and 
the optimized buffer was buffer T (Amaxa).  
 
Table2.1  The sequences of Morpholinos for knock-down experiments 
Knock-down target Synthesized MO(5’—3’) Target location 
Negative control CCTCTTACCTCAGTTACAATTTATA  
ORF086R CATGGTGTTTGGTAGTGTTTACGTT -21 -- +3 
 
After transfection with control antisense morpholino and ORF086R antisense morpholino, 
GE cells were growed for 24~40 hours, which helped cells to recover and grow. 
Optimized time for ORF086R asMO transfection is 24 hours. The second day, the well 
growed GE cells infected by SGIV at a multiplicity of infection (MOI) of 0.2, after 
infection, collect cells separately at different time point of  24 h.p.i., 48 h.p.i., and 72 
h.p.i.. Wash the collected cells three times with PBS and centrifuge at 2000rpm. Lysis 
cells with RIPA and centrifuge at high speed (13000rpm) for 10 minutes, the supernatant 
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 were the lysised proteins from host cells and virus and kept for Western blot. All the 
above steps were operated at 4oC. 
 
2.3.3 Western blot  
Two identical SDS-PAGE gels are run side-by-side. One of them was stained and used as 
a control. The other one was placed in the electro-blotting buffer for the transfer of the 
proteins to a PDVF membrane (Bio-rad Company) at 30 volt for overnight (70 volt for 3 
hours). The PDVF membrane was then blocked with 2.5 % fat-free milk and 0.5 % BSA 
in 1X TTBS buffer for 1 h at room temperature. After that, the membrane was washed 
three times in 1X TTBS buffer. 15 ml of 15,000X diluted antibodies was added to the 
membrane and incubated for 1 h at the room temperature. The membrane was then 
washed three times with 1X TTBS buffer. 10 ml of 5000X diluted goat anti-rabbit IgG 
was added to the membrane. This was washed three times with 1X TTBS buffer and 
stained with the ECL stain (Amersham Biosciences). The film was then developed in the 
dark room for 1 to 15 minutes depending on the background.  
 
2.3.4 TCID50
50% tissue culture infectious dose (TCID50) assay is a way to detect virus infectivity. The 
cells were infected at MOI of 0.2, at 24h after asMO transfection and incubated in 1ml 
culture media containing virus of desired amount at 27oC. After 2h virus absorption, non-
attached virus was removed, and fresh media was added in. The cells were detached by 
cell scrapper at 24 h.p.i., 48 h.p.i., and 72 h.p.i., collected and homogenized with syringe 
10~15 times to release cell associated viruses. 
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 The 96-well titration plate was prepared one day before virus titration assay. Each well 
was coated with 104 GE cells. Collected virus suspension was centrifuged at 1krpm, 
5mins to pallet down cell debris. The supernatant was serially diluted from 10-1 to 10-8, 
the optimized dilution of virus titer is from 10-3 to 10-10. For each dilution factor, 100ul 
virus suspension was added to each well with 5 repetitions. The plates were incubated at 
27oC and observed for cytopathic effect (CPE) day by day until 8th day. For each asMO 
treatment, three independent transfection and titration experiments were performed. 
 
2.3.5 Transmission Electron Microscopy 
Cells were detached from culture flask by cell scraper and pelleted down by 
centrifugation. Cells were fixed in PBS containing 2.5% glutaraldehyde and 2.5% 
paraformaldehyde overnight at 4oC, and postfixed with 0.5% osmium tetroxide. The fixed 
sample was dehydrated in ethanol gradient step wisely. The ethanol was removed by 
treatment with 100% propylene oxide. Finally, the sample was embedded using the Spurr 
resin (Sigma) in 70oC oven until harden. Sample block was section to 99nm thin by 
microtome (Reichert). Thin sections were holded by 100 mesh copper hex grids (SPI) 
covered with formvar film. This grid holding sample sections was stained with 2% uranyl 







 2.4 Materials 
 
2.4.1 Enzymes and other proteins  
Enzymes for molecular biology were mainly purchased from New England Biolabs, and 
other proteins were mainly from Sigma.  
 
2.4.2 Kit and reagents  
Kits for molecular biology are mainly from QIAGEN (refer to appendices for details).  
 
2.4.3 Culture medium 
2.4.3.1 LB medium  
1L: 
 10 g Bacto tryptone 
5 g yeast extract  
10 g NaCl.  
The pH of the LB medium was adjusted to neutral with 2 N NaOH and made up to a final 
volume of 1 liter with ddH2O. The medium was then sterilized by autoclaving (For plates, 
medium was supplemented with 10 g/l agar and sufficient amount of appropriate 
antibiotics). 
 
2.4.3.2 2X YT Media 
1L: 
16g Bacto tryptone 
10 g yeast extract  
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 5 g NaCl.  
The pH of the LB medium was adjusted to 7.4 with 2 N NaOH and made up to a final 
volume of 1 liter with ddH2O. The medium was then sterilized by autoclaving (For plates, 
medium was supplemented with 10 g/l agar and sufficient amount of appropriate 
antibiotics). 
 
2.4.4 Antibiotic stock solution 
2.4.4.1 IPTG stock solution  
IPTG was dissolved in sterile water to a final concentration of 1 M (2.38 g per 10 ml). 
The stock solution was sterile-filtered and stored in aliquots at –20 °C until use. The 
stock solution was diluted 1:1000 when added to the medium, unless otherwise indicated.  
 
2.4.4.2Ampicillin stock solution  
Ampicillin was dissolved in sterile water (1 g/ 10 ml) to a final concentration of 100 
mg/ml. The stock solution was sterile-filtered and stored in aliquots at –20 °C until use. 
The stock solution was diluted 1:1000 when added to the medium. 
 
2.4.5 Buffer for protein purification 
2.4.5.1Buffers for Ni-NTA purification under native conditions  
i. Lysis buffer (buffer Z): 25 Tris pH 7.5, 25Mm Potassium Phosphate pH6.8, 500 mM 
NaCl, 10% Glycerol,1 mM DTT. 
ii. Equilibrium buffer: 10mM Tris pH7.5, 250 mM NaCl, 10% Glycerol 
iii. Elution buffer:  
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 10mM Tris pH7.5, 250 mM NaCl, 10% Glycerol, 25mM imidazole 
10mM Tris pH7.5, 250 mM NaCl, 10% Glycerol, 250mM imidazole 
10mM Tris pH7.5, 250 mM NaCl, 10% Glycerol, 500mM imidazole 
10mM Tris pH7.5, 250 mM NaCl, 10% Glycerol, 750mM imidazole 
(Different concentration of imidazole were used depending on the binding ability) 
 
2.4.5.2Buffers for ion exchange purification 
Buffer A: 25mM Tris pH7.5, 0.4mM DTT, 0.1mM EDTA, 10mM NaCl 
Buffer B: 25mM Tris pH7.5, 0.4mM DTT, 0.1mM EDTA, 1M NaCl 
 
2.4.5.3 Buffers for gel filtration purification  
25mM Tris pH7.5, 4mM DTT, 0.5mM EDTA, 500mM NaCl 
 
2.4.6 E.coli strains  

































3.1 Introduction of ORF086R 
SGIV genome was sequenced with 162 predicted ORFs (Song et al., 2004), in which 127 
ORFs  were confirmed to be transcriptionally active (Chen et al., 2006) and 26 proteins 
of this virus were identified using peptide mass fingerprints generated from MALDI-TOF 
MS (Song et al., 2004). The subsequent proteomics investigation using 1-DE-MALDI 
and LC-MALDI workflows resulted in a more comprehensive and precise identification 
of the SGIV proteome with another 25 SGIV proteins newly identified (Song et al., 2006). 
11 new proteins were identified by iTRAQ (Chen & Tran et al., 2008). A total of 75 viral 
proteins have been confirmed by proteomic approaches. 
 
OR0F86R was first identified by 1-D SDS-PAGE MALDI-TOF MS/MS, (Song et al., 
2006). In 2008, Chen and Tran et. al (2008) used iTRAQ to analysis host and viral 
proteins and ORF86 was one of the 49 identified viral proteins.  
 
ORF086R is an immediate-early gene (Chen et al., 2006). It has a highly conserved 
domain with other Iridoviridae family (Figure3.1), which may play an important role in 
virus infection and replication. In this part, we have carried out a comparative sequence 
analysis of ORF86 and other proteins in the family of Iridoviridae using bioinformatics’ 



















3.2 Gene construction, expression and purification 
 
The pET15b vector was used for gene construction. ORF086R contains 154 amino acids 
with 20KDa as recombinant fusion protein. 





Figure3.2 The expression of ORF086R-pET15b. Lane S is supernatant, lane P is pellet. 
 
As the protein was insoluble (Figure3.2), denature purification was carried out for protein 
refolding to solve the problem. The protein could be eluted from beads, but could not be 
refolded, either using on beads refolding or dialysis refolding. The expression level of the 
protein in BL21 was high. Then the denatured protein (about 5 mg for one rabbit) was cut 
from gel and used to raise rabbit antibody.  
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 Uninfected and infected cells for Western blot assay were prepared separately. Western 
bolt assay was used to detect the specificity of antibody. (Figure3.3) 
 
 





Figure3.3 Western blot assay of ORF086R in virus infected cells 
 
The Western blot assay showed that the antibody (1:500) of ORF086R could specifically 
bind to the protein in infected cells. 
 
As the protein was insoluble after expression with the vector pET15b, other vectors were 
used. pGEX 6p-1 is a vector with a GST tag which may increase the protein solubility. 
Vector pET28b is also containing a His tag which is expressed on the C terminal. Vector 
pET28a-sumo (from Adam Yuan’s lab) is a modified vector with an additional sumo tag 





The solubilities of ORF086R expression with different vectors are showed below 
(Figure3.4). ORF086R was expressed as inclusion body in both vector pET28b (MW18) 
and pGEX 6p-1(picture not show), and soluble in vector pET28a-sumo (MW35). 
 
a b 
                                                             
ORF086R 
ORF086R 
    S         P                                       S         P   
Figure3.4 Solubility of ORF086R expression in different vectors. Figure a showed the 
expression in vector pET28b. Figure b showed the expression in vector pET28a-sumo. (S: 
supernatant; P: pellet) 
 
 
3.3 Knockdown Platform Technology for the Studies of ORF086R 
3.3.1 Viral Protein Expression Analysis with Western Blot Assay 
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 Virus infected cells were transfected with control antisense morpholino and ORF086R 
antisense morpholino. Cells were collected separately at different time point of 24h.p.i, 
48h.p.i, and 72h.p.i. Western blot analysis results were showed as below (Figure3.5). 
 
 
         asMO86 asMOctrl               asMO86 asMOctrl               asMO86 asMOctrl  




Figure 3.5 Western blot assay of ORF086R knock-down time course study 
 
Figure 3.5 showed that asMO86 could reduce the expression level of ORF086R 
compared with control. The expression level was extremely low by 48h.p.i. and was 
recovered by 72h.p.i. Due to more ORF086R mRNA were produced with the growths of 
GE cells, the total amount of antisense was not enough to interfere all ORF086R mRNA 
in cells. More proteins were expressed, which caused the increase of expression level at 
72h.p.i. 
 
3.3.2 Virus infectivity analysis 
Based on the previous study, 50% tissue culture infectious dose (TCID50) assay could be 
used for detecting virus infectivity. Cells were collected at 24h.p.i., 48h.p.i., and 72.p.h.i., 
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 Three independent transfection and titration experiments were performed for each asMO 
treatment (Figure3.6). Titration was triplicate for each transfection experiment. The 
TCID50 value and virus titer from titration assay was calculated by method of Reed & 
Muench (1938). The result was showed in Figure 3.6 
 
 
Figure 3.6 Virus infectivity test of TCID50 
 
The above result of TCID50 assay showed that the virus titer was increased in the course 
of infection both in control and knockdown groups. But the virus titer between control 
and knockdown groups was no significantly difference which indicated that the virus 




 3.3.3 Effects on viral proteins after ORF086R knockdown 






  asMO86 asMOctrl
Figure 3.7 Western blot assay of ORF086R knock-down at 48h.p.i. 
 
To detect the influences of ORF086R knock down on the expression level of other viral 













Figure3.8 Western blot assay of other viral proteins. ORF0158L is an early gene protein, 
ORF075R, ORF026R and ORF018L are all late gene proteins. 
 
Figure3.8 showed there was no significant affect to the expression level of other SGIV 
proteins after knocking-down of ORF086R. Hence, ORF086R might not regulate the 
proteins expression level of these viral.  
 
 
3.3.4 Transmission Electron Microscopy 
Transmission electron microscopy was used to study the morphology of virus after 












Figure 3.9 TEM study of ORF086R knock-down. The structure of virus in cells with the 
magnification of 20,000X (a), 15,000X (b), and 30,000X (c,d) .  
 
Figure3.9 showed that for virus phenotype there was no difference between asMOctrl and 
asMO86 knockdown. The virus phenotype did not change after ORF086R knockdown. 
The result agreed with the previous infectivity experiment, that is, ORF086R might not 
regulate the four viral proteins available in our lab. It might influence other viral proteins 




 3.4 Structural study of ORF086R 
 
3.4.1 The secondary structure prediction of ORF086R 
The secondary structure prediction of ORF086R is shown in Table3.1 and Figure 3.10. It 
showed that ORF086R is a highly structural protein base on secondary structure 
prediction. 
 
Table 3.1 Prediction of ORF086R secondary structure 
 
sec str type Helix βsheet Loop 
% in protein 9.09 51.95 38.96 
 




Figure 3.10  Prediction of ORF086R secondary structure. The first line labeled the amino 
acids  number of the protein. The yellow streaks are for β sheet, the red streaks are for 






3.4.2 ORF086R-pET28a-sumo purification 
 
It shows ORF086R has high solubility with vector pET28a-sumo. The fusion protein was 
purified by His column and gel filtration (Figure 3.11, 3.12). Purification methods are 
described in part 2.2.4 and 2.2.6. 
 
The protein could be eluted from His column at different concentration of imidazole. In 
our study, most of them were eluted at 750mM imidazole (Figure 3.11) and the protein 
purity was also higher at high imidazole elution. 
 
After protein elution from His column, superdex 200 was used for next step purification 
(Figure3.12). Two peaks were detected: the first one may be the dimer of this protein, as 
there is a cysteine in protein sequence; the second peak is the monomer of the protein. 

















      
 
b        
 
 M     1   2      3     4    5    6     7    8   9    10  11  12  
35KD 
            
Figure 3.11 ORF086R-pET28a-sumo his column purification. (a) is FPLC picture of his 
column purification at different concentration of imidazole, collect sample fractions 
every 5 ml. (b) is SDS-PAGE gel after his column purification, lane1is from peak1, lane2 
is from peak2, lane3-12 are from peak3. 
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  1     2      3     4       5      6      7    8       9     10      11    12   M 
35KD 
      
Figure 3.12 ORF086R-pET28a-sumo gel filtration purification. (a) is FPLC picture of gel 
filtration purification, collect sample fractions every 5 ml. (b) is SDS-PAGE gel after gel 




 3.4.3 Crystal screening of ORF086R-pET28a-sumo 
The protein was purified by His column and superdex 200 and the purity was used for 
crystal screening. Two protein concentrations were used: 15mg/ml and 8mg/ml. Hanging 
drop and sitting drop are methods usually used for crystal screening. Hanging drop was 
used in this study. Crystal screening of the protein with sumo tag used 25 kits under more 
than 2000 different conditions. 
 
Tiny crystals were observed at 5th month after screening (Figure 3.13). As the condition 
may change a lot during this period and it still needs to be optimized for further study. 
 
                         
 
Figure 3.13 Tiny crystals of ORF086R-pET28a-sumo. Buffer condition: 20mM sodium 





3.4.4 Removal of sumo tag from ORF086R 
 
ORF086R was soluble with sumo tag and sumo protease was used to remove sumo tag 
from protein. The sumo protease can cut out sumo from protein through recognizing 
specific amino acids site and three dimensional structures. After cutting, two bands were 
shown(Figure3.14), MW35KD band was the uncut protein and the lower band was a 
mixture of ORF086R and sumo. The MW of ORF086R and sumo are similar(ORF086R 
MW is around 18KD. Sumo MW is 12KD, but on gel it showed around 18KD). The 
protein was precipitated after cutting. To separate the supernatant and precipitate, 
centrifugation was perfomed and SDS-PAGE was used for examination (Figure3.14).  
 
18KD bands were sent (two bands were circled) to MS idenfication. The results showed 
the supernatant was sumo and the pellet was protein ORF086R. It is possible that 
ORF086R was not stable in this buffer (buffer pH7.4, protein pI is 7.9) after cutting. 








1            2                       3                  4            5     
 
Figure 3.14 Removal of sumo tag from ORF086R by sumo protease. Lane 1: marker; 
lane 2: precipitate pellet after cutting; lane 3: supernatant after centrifuge; lane 4: total 
proteins after sumo protease cutting; lane 5: ORF086R-pET28a-sumo as control.  
 
 
3.4.5 ORF086R-pET28a-sumo trypsin digestion 
 
ORF086R was not stable without sumo tag. Trypsin was used to digest the protein to 
check whether it has some stable domains. Result showed there was one main band after 
trypsin digestion and was sent for MS analysis (Figure 3.15). The main band might 
corresponded to one domain of ORF086R which was stable with sumo tag. Trypsin 
digestion was through recognization of amino acid K. The MS result showed that the 
main band is 85 amino acids (K is the 85th amino acid). The first 85 amino acids may 
form a stable domain, which is soluble in buffer.  
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Based on the secondary structure prediction (Figure 3.10), two truncated constructs (1-85) 
(1-105) were cloned and both were soluble using vector pET28a-sumo.  
 
                   
MS 
1         2           3          4            5          6          7          8           9      10 
 
 
Figure 3.15 ORF086R-pET28a-sumo trypsin digest. Lane 1: maker; lane 2: ORF86R-
pET15b as control; lane 3-5: protein digested with 40μl 0.2% trypsin at different digest 
time(lane 3: 24h, lane 4: 12h, lane 5: 6h); lane 6-9: proteins digested with 20μl 0.2% 
trypsin at different digest time(lane 6: 36h, lane 7: 24h, lane 8: 12 h, lane 9:6h); lane 10: 








3.4.6 ORF086R (1-85)-pET28a-sumo Purification 
 
ORF086R (1-85) was soluble with vector pET28a-sumo and the bacterial culture 
condition was 20oC induced overnight at IPTG 0.3mM. The purification was also similar, 
firstly, the protein was eluted with different concentration of imidazole (Figure 3.16). 
Secondly, the protein was further purified by superdex 200(Figure3.17). 
 
As the figure shown, the protein was eluted at different concentration, but most of the 
proteins were eluted at 250mM imidazole. After the protein was purified by gel filtration, 
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Figure 3.16 ORF086R (1-85)-pET28a-sumo His column purification. (a) is FPLC picture 
of his column purification, collect samples fraction every 5 ml. (b) is SDS-PAGE gel 
after his column purification, lane1-7 are from peak1, lane8-11are from peak2, lane13-14 
are from peak3. 
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Figure 3.17 ORF086R (1-85)-pET28a-sumo his column purification. (a) is FPLC picture 
of his column purification, collect sample fraction every 5 ml. (b) is SDS-PAGE gel after 




 3.4.7 Removal sumo tag from ORF086R (1-85) 
he ORF086R (1-85) was soluble with sumo tag and could be purified. To test whether 
o separate the uncut protein, sumo tag and ORF086R (1-85) and SP column was used. 
ine. 
Figure 3.18  Removal sumo tag from ORF086R (1-85) by sumo protease. Lane 1:protein 
 
T
the protein was stable without sumo, sumo protease was used. After cutting, the protein 
was stable (Figure 3.18).  
 
T
The ion exchange purification results showed the protein could be separated from sumo 
(Figure 3.19b lane 3 lower band). Figure 3.19 b showed that some ORF086R (1-85)  
formed dimer (lane1, 2 and lane 3 upper bands ,confirmed by MS) as it had one cyste
As the protein had a small molecular weight, superdex 30 was used (Figure 3.19). The 





mixture after sumo protease cutting; lane 2: marker. 
 
85 
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                1             2            3       
 85 dimer  




Figure 3.19 ORF086R (1-85) purification. (a) is SP column purification to separate 
appeared. 
ORF086R (1-85) and sumo. (b) is SDS-PAGE gel to determine figure a peaks, lane F is 
flow through after binding, lane 1-2 are from peak1, lane 3-4 are from peak2. (c) is SDS-
PAGE gel after superdex 30 purification, FPLC figure did not show and only one peak 
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3.4.8 ORF086R (1-85) CD and DLS study 
dy the secondary structure of protein. The 
oncentration of ORF086R (1-85) was around 0.2mg/ml. The optimized buffer condition 
ure3.20). In the upper picture of Figure 3.20, 
 showed the spectra of protein secondary structure and in the lower picture, it showed 
ue which was mostly used in structure study, 
 can detect the homogeneity of protein, and also can provide rough information of 
 the right one 
owed the average diameter of proteins in each detection. The proteins are almost in 
 
Circular Dichroism (CD) is a method to stu
c
for CD study was phosphate buffer, pH6.8. 
 
Result showed the protein has structure (Fig
it
the salt concentration of the protein is in believable range and would not infect the 
protein secondary structure. Compared with Figure 1.3, it is similar to α helix structure, 
which is different for the previous secondary structure prediction (Figure 3.11). Probably, 
its secondary structure is formedβsheets, but theseβsheets formed αhelix further, 
which  was detected by CD spectroscopy.  
 
Dynamic light scattering (DLS) is a techniq
it
protein molecular weight. There is no limitation for protein concentration or buffer. In 
this study, the concentration of protein was 6mg/ml in 20mM phosphate buffer pH 
6.8(Figure 3.21), under this condition, the protein kept stable and soluble.  
 
In Figure 3.21, the left figure showed the time course of the DLS, and
sh
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 similar size, except one peak is very high and may be it is a bubble. Base on the diameter 
of proteins, the machine can calculate the around molecular weight of proteins. DLS data 
showed that the protein was homogenous, the MW of the protein around 10KD, but the 








































3.4.9 ORF086R (1-85) 1-D NMR study 
ight protein which can be used for NMR study. 
ure and unlabeled protein is suitable for 1-D NMR study (Figure3.22). 
ular (H) Proton, 
arbon and spectra of other nuclei. It could provide information about the protein, such 
 
ORF086R (1-85) is a small molecular we
P
 
1-D NMR spectroscopy was using unlabeled protein to detect the reg
C
as whether the protein is well folded or the side chains of protein are overlapped. Both 
figure 3.22 results showed that in different buffers, the H spectra of the protein was no 
much different. In the range 7-9ppm, each peak should stand for one amino acid, but all 
these peaks are not separated very clearly, which pointed out that some amino acids are 
overlapped. From the two NMR results, the protein was aggregated and it was not 













Figure 3.22 1-D NMR study of ORF086R. (a) and (b) are ORF086R (1-85) with different 
buffers at different concentrations. (a) is ORF086R (1-85) in 20mM MES, pH6.0, 
150mM NaCl at concentration about 8mg/ml. (b) is ORF086R (1-85) in phosphate buffer 






 3.5 Discussion 
 
ORF086R was an immediate early gene, which is only conserved in iridovirus families 
with unknown function. During the process of the virus replication, virus genes are 
expressed in a well-regulated temporal cascade involving the sequential expression of 
immediate early (IE), delayed early/early (DE/E), and late viral messages. (Chinchar et 
al., 2008) In the cytoplasm, the IE genes mRNA were translated into proteins, then, E/L 
genes mRNA were translated into proteins. The process of viral proteins transcription 
indicated that IE genes proteins are important for E/L genes proteins.  
 
Some immediate early genes could alter normal cell processes, such as regulation of the 
cell cycle, to insure the generation of progeny viral particles (Castillo and Kowalik, 2004).  
IE86, an immediate early gene of HCMV (human cytomegalovirus), which promote virus 
replication as well as preventing the premature death of the infected cell (Castillo and 
Kowalik, 2002). Two immediate early genes of HSV(herpes simplex virus), ICP4 and 
ICP27 are essential for expression of  E and L genes, and also have been shown to 
possess antiapoptotic activities during viral replication (Nguyen and Blaho, 2007). 
 
ORF086R is an immediate early protein, which may be essential and play a very 
important role for the E/L genes proteins. To ascertain the precise role of ORF086R, 
functional and structural studies were performed. 
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 Knock down platform was carried out by antisense morpholino, which is an appropriate 
tool for transiently and specifically inhibiting expression of ranavirus genes. In this study, 
ORF086R asMOs was designed to block translation of targeted mRNA, and the 
assessment of the effectiveness was performed with Western blot, which indicated the 
protein expression level of ORF086R was reduced. 
 
The antibody of ORF086R was produced, which can specifically recognize the protein in 
infected cells. ORF086R was successfully knockdown with antisense morpholino. 
Reduction of ORF086R did not significantly affect virus replication after TCID50 assay. 
The morphology of virus was detected by TEM after ORF086R was knocked down 
(Figure3.9). The phenotypes of virus had no significant difference between control and 
asMO86 knock down. It would suggest that ORF086R is not a structure protein and makes 
less contribution to virus structure. 
 
As IE genes are essential and important for E/L genes, the IE protein could regulate E/L 
proteins. Through knock down platform, even though the ORF086R expression level was 
reduced, the expression of other viral proteins were not affected (Figure 3.8). Western 
blot assay showed that this protein did not regulate the four viral proteins available in our 
lab (Figure3.8). Among them, one is E protein, and the rest three are L proteins. It might 
because of the four proteins are not at the downstream of this protein transcription or 
translation. It may regulate other viral protein, however it is hard to confirm whether 
other viral proteins amounts were reduced after ORF086R was knocked down due to the 
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 limitation of antibody.  Co-Immunoprecipitation (Co-IP) can be used to study the binding 
partners of ORF086R, either viral or host proteins. 
 
Another way to detect ORF086R interaction proteins is iTRAQ, which is a proteomic 
method that can be used for quantitatively analyzing the virus and host proteins after 
virus infection and protein knockdown. It can analyze four or eight samples at the same 
time. The sample is labeled with iTRAQ reagents, detected by LC-MALDI MS. Through 
the data analysis, it may identify some new viral proteins, or it can provide information 
about viral and host protein.  
 
Previous studies showed that viral IE proeins can control host cell growth by regulating 
the cell cycle, preventing cellular growth arrest and/or apotosis, which pay a critical role 
in promoting a proliferative environment that maximizes virus replication (Xia et al., 
2009). AsMo86 knock down study showed ORF086R may not be essential for virus 
replication. Possibly, ORF086R may contribute indirectly to virus replication by 
providing a conductive environment by modifying host-cell growth. ORF086R is 
localized in the cytoplasm (Xia, et. al 2009), which indicated that this protein may make 
contributions to the formation of virus factories and virus assembly in the late stage of 
virus infection.  
 
From ORF086R konock down study, it is not an essential gene for virus replication and it 
may involve in aspects of viral replication in host cells. Non-essential viral genes are 
genes that encode chemokines or chemokine receptors, anti-apoptotic genes, genes that 
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 contribute to the infection of particular cell types, and genes that modulate host immune-
cell recognition of virally infected cells (Mocarski, 2002). ORF086R overexpression 
could increased the yield of virus in cells (Xia, et. al 2009.), which also provided 
envidences that ORF086R might be a protein involved in cell growth, thereby 
contributing to viral replication.  
 
Virus immediate early genes may also play a role of immune evasion to help virus 
replicate in host cells. FV3 46K is an immediate early gene from frog virus 3 and was 
identified as a homolog to T4 RNA ligase. This protein may repair tRNAs damaged 
either as a result of a host-induced antiviral response or as a consequence of the virus-
induced degradation of cellular RNA (Chinchar et al., 2008). 
 
According to our studies, ORF086R may not directly affect on virus replication and 
assembling. It could indirectly regulate viral proteins or control cell growth to impact 
virus replication and assembling. As ORF086R is an immediate early gene, it did not play 
a role in virus replication; however, it may help virus replication in host cells, such as 
playing a role of antiapotosis. Apoptosis during virus infection represents an important 
virus–host interaction process, which likely influences viral pathogenesis, so binding 
partners of ORF086R could help understand the accurate role of this protein. 
 
As the latest NCBI blast result, this protein is only homologous to the iridovirus family 
members. Three dimension structure determination of ORF086R is not only important to 
SGIV, but also make contributions to Iridovirus family. 
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The full-length and truncated ORF086R are constructed, and expressed (all of ORF086R 
with sumo tag are soluble), all soluble protein were purified for crystal screening. 
Secondary structure prediction and CD results showed that the protein was likely folded. 
Though the secondary structure prediction showed that most of ORF086R is beta sheet 
structure, but the truncated protein CD result showed its secondary structure was likely 
alpha helix (Figure 3.20). N-NgR is a protein which three dimensional structure was 
solved by X-ray crystallography. Its secondary structure is beta sheet, but it adopts a 
leucine-rich repeat fold which gives rise to helix like CD spectra due to its unique 
solenoid like fold (Song, 2009). According to the prediction of secondary structure, 
truncated ORF086R may fold into helix which made the CD spectra appeared like an 
alpha helix. 
 
DLS data indicated that the protein in the solution was homogenous, six or seven single 
protein particles formed one unit, so the average MW is around 70KD. 1D NMR is the 
first step study for NMR study, it detect the hydrogen spectroscopy. It cannot show what 
the secondary structure of protein. In 1-D NMR, if protein is highly structured with β
sheets, it can be detected, but αhelix and random coli can not be detected.  The protein 
may beαhelix structure which is same to the CD results. The peaks in 7-9 ppm are 
hydrogens spectroscopy ligated with nitrogen, and they are not sharp, which means 
protein amino acids are overlapped and formed aggregate. It is better to optimize the 
buffer condition or protein concentration for the next step study. 
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 The crystal of full-length ORF086R with sumo tag was observed, however, the buffer 
condition was needed to be further optimized. As the tiny crystals were observed at the 
5th month after screening, the buffer condition may change a lot. This protein was 
soluble with sumo tag, but it was only stable with high salt, when the buffer salt is 
reduced, it became unstable. If the crystal was optimized, the structure can be determined, 
it will facilitate further studies. 
 
Another candidate ORF018R which might regulate ORF086R phosphorylation (Xia, et 
al., 2009) will be considered for further study, this protein is highly expressed in bacterial 
culture. After purification, it is stable. The MW of this protein is 31 KD, which can both 
















Branden, C., and Tooze, J. 1999. Introduction to Protein Structure. Garland Publishing, 
New York, p. 251-281. 
 
Castillo JP, Kowalik TF. 2002. Human cytomegalovirus immediate early proteins and 
cell growth control. Gene 290:19–34. 
 
Castillo JP, Kowalik TF. 2004. HCMV infection: modulating the cell cycle and cell death. 
Int Rev Immunol 23:113–139. 
 
Chen, L.M., Wang, F., Song, W.J., Hew, C.L., 2006. Temporal and differential gene 
expression of Singapore grouper iridovirus. Journal of General Virology 87, 2907–2915. 
 
Chen LM, Tran BN, Lin Q, Lim TK, Wang F, Hew CL. 2008. iTRAQ analysis of 
Singapore grouper iridovirus infection in a grouper embryonic cell line. J Gen Virol 
89:2869-76. 
 
Chu, B. 1992. Laser Light scattering: Basic Principles and Practice. Academic 
Press. ISBN 0121745511. 
 
 66
 Chua, F.H., Ng.M.L., Ng. K.L., Loo. J.J., and Wee, J.Y. 1994. Investigation of outbreaks 
of novel disease, ‘Sleepy Grouper disease’, affecting the brown-spotted grouper, 
Epinephelus tauvina Forskal. J. Fish. Dis. 17, 417- 427. 
 
Eaton, H.E., Metcalf, J., Penny, E., Tcherepanov, V., Upton, C., Brunetti, C.R. 2007. 
Comparative genomic analysis of the family Iridoviridae: re-annotating and defining the 
core set of iridovirus genes. Virology Journal 4(11). 
 
Filler, Aaron. 2009. "The History, Development and Impact of Computed Imaging in 
Neurological Diagnosis and Neurosurgery: CT, MRI, and DTI". Nature 
Precedings.doi:10.1038/npre.2009.3267.5
 
Goorha, R. 1982. Frog virus 3 DNA replication occurs in two stages. J Virol. 43:519- 
528. 
 
Goorha, R., and P. Dixit. 1984. A temperature-sensitive mutant of frog virus 3 is 
defective in second stage DNA replication. Virology 136:186-195 
 




 Hudziak, R.M., Barofsky, E., Barofsky, D.F., Weller, D.L.,  Huang, S.B., Weller, D.D. 
Resistance of morpholino phosphorodiamidate oligomers to enzymatic degradation. 
Antisense Nucleic Acid Drug Dev. 1996, 6(4), 267-272. 
 
J. Keeler. 2005. Understanding NMR Spectroscopy. John Wiley & Sons. ISBN 
0470017864. 
 
John Philo. 2003. Measuring Comparability of Conformation, Heterogeneity, and 
Aggregation with Circular Dichroism and Analytical Ultracentrifugation, invited talk, 
State of the Art Methods for the Characterization of Biological Products and Assessment 
of Comparability, NIH, June 2003 
 
Livak, K.J., and Schmittgen, T.D. 2001. Analysis of relative gene expression data using 
real-time quantitative PCR and the 2-CT method. Methods 25, 402-408. 
 
Lu, L., Zhou, S.Y., Chen, C., Weng, S.P., Chan, S.M., He, J.G., 2005. Complete genome 
sequence analysis of an iridovirus isolated from the orange- spotted grouper, Epinephelus 
coicodes. Virology 339, 81-10. 
 
Mocarski ES.2002.  Immunomodulation by cytomegaloviruses: manipulative strategies 
beyond evasion. Trends Microbiol 10:332–339 
 
 68
 Marie L. Nguyen and John A. Blaho 2007. Apotosis during herpes simplex virus 
infection. Advances in virus research  69:67-97 
 
Qin, Q.W., Lam, T.J., Sin, Y.M., Shen, H., Chang, S.F., Ngoh, G.H., Chen, C.L., 2001. 
Electron microscopic observations of a marine fish iridovirus isolated from brown-
spotted grouper, Epinephelus tauvina.J. Virol. Methods. 98, 17- 24. 
 
Qin, Q. W., S. F. Chang, G. H. Ngoh-Lim, S. Gibson-Kueh, C. Shi, and T. J. Lam. 2003. 
Characterization of a novel ranavirus isolated from grouper Epinephelus tauvina. Dis. 
Aquat. Organ. 53:1-9. 
 
Rajni Hatti-Kaul, Bo Mattiasson. 2003. Isolation and purification of proteins. New 
York, Marcel Dekker. 
 
Reed L.J., Muench H. 1938. A simple method of estimating fifty percent end points. Am 
J Hyg 27:493-497 
 
Sample R, Bryan L, Long S, Majji S, Hoskins G, Sinning A, Olivier J, Chinchar VG. 
2007. Inhibition of iridovirus protein synthesis and virus replication by antisense 
morpholino oligonucleotides targeted to the major capsid protein, the 18 kDa immediate-
early protein, and a viral homolog of RNA polymerase II. Virology 358, 311-20. 
 
 69
 Song J.X. 2009  Insight into “insoluble proteins” with pure water.  FEBS letters 583: 953-
958 
 
Song. W., Qin. Q., Qiu. J., Huang. C., Wang. F., and Hew. C. L. 2004. Functional 
genomics analysis of Singapore grouper iridovirus: complete sequence determination and 
proteomic analysis. Journal of Virology  78: 12576- 12590. 
 
Song, W., Lin, Q., Joshi, S.B., Lim, T.K., and Hew, C.L. 2006. Proteomic Studies of the 
Singapore Grouper Iridovirus. Mol. Cell. Proteomics 5, 256-264. 
 
Summerton, J. 1999. Morpholino Antisense Oligomers: The Case for an RNase-H 
Independent Structural Type. Biochimica et Biophysica Acta, 1489, 141-158. 
 
Summerton, J. Morpholinos and PNAs compared. Lett. Pep. Sci. 2004, 10, 215-236. 
 
Summerton, J. 2007. Morpholino, siRNA, and S-DNA compared: impact of structure and 
mechanism of action on off-target effects and sequence specificity. Current topics in Med. 
Chem. 7, 651-660. 
 
Summerton, J., and Weller, D. Morpholino Antisense Oligomers: Design, Preparation 
and Properties. Antisense Nucleic Acid Drug Dev. 1997, 7, 187-195. 
 
 70
 Tan, W. G. H., T. J. Barkman, V. G. Chinchar, and K. Essani. 2004. Comparative 
genomic analysis of frog virus 3, type species of the genus Ranavirus (family 
Iridoviridae). Virology 323:70-84 
 
Teng Y, Hou Z, Gong J, Liu H, Xie X, Zhang L, Chen X, Qin QW. 2008. Whole-genome 
transcriptional profiles of a novel marine fish iridovirus, Singapore grouper iridovirus 
(SGIV) in virus-infected grouper spleen cell cultures and in orange-spotted grouper, 
Epinephulus coioides. Virology. 377:39-48.
 
Tidona, C.A., Schnitzler, P., Kehm, R., Darai, G. 1998. Is the major capsid protein of 
iridoviruses a suitable target for the study of viral evolution? Virus Genes 16, 59-66. 
 
Tsai, C.T., Ting, J.W., Wu, M.S., Wu, M.F., Guo, I.C., Chang, C.Y. 2005. Complete 
genome sequence of the grouper iridovirus and comparison of genomic organization with 
those of other iridoriviruses. Journal of Virology 79, 2010-2023. 
 
V.G. Chinchar, A.Hyatt, T.Miyazaki, T.Williams. 2008 Family Iridoviridae: Poor Viral 
Relations. Microbilogy and Immunology 328: 123-170. 
 
Wang, F., Bi, X., Chen. L.M., and Hew, C.L. 2008. ORF018R, a highly abundant virion 
protein from Singapore grouper iridovirus, is involved in serine/threonine 
phosphorylation anf virion assembly. Journal of General Virology 89, 1169-1178. 
 
 71
 Whitmore L, Wallace BA. 2008. "Protein secondary structure analyses from circular 
dichroism spectroscopy: methods and reference databases". Biopolymers 89 (5): 392–
400.doi:10.1002/bip.20853. PMID 17896349. 
 
Williams, T. 1996. The iridoviruses. Advances in virus research. 46: 345-412. 
 
Williams, T., Barbosa-Solomieu, V.,  and  Chinchar, V. G. 2006. A decade of advances 
in iridovirus research. Advances in virus research 65: 173-248. 
 
Wu J.L., Chan R., Wenk M.R. and Hew C.L. 2010. Lipidomic study of intracellular 
Singapore grouper iridovirus. Virology 399, 248-56. 
 
Xia L.Q., Cao J.H., Huang X.H. and Qin Q.W. 2009 Characterization of Singapore 
grouper iridovirus ORF086R, a putative homolog of ICP18 involved in cell growth 












ORF MW PI stage vector solubility antibody 
132 31.36 9.5 IE pET32aM insoluble NA 
        pET28a-sumo insoluble   
        pGEX-6p-1 insoluble   
133 9.56 3.57 IE pET15b insoluble NA 
        pET28a-sumo soluble   
        pGEX-4T-1 soluble   
99 9.07 5.13 E pET15b insoluble rabbit poly 
        pET28a-sumo soluble mouse mono 
        pGEX-4T-1 insoluble   
122 24.25 9.48 E pET32aM insoluble NA 
        pET28a-sumo insoluble   
        pGEX-6p-1 insoluble   
157 19.73 8.8 E pET32aM insoluble NA 
        pET28a-sumo insoluble   
        pGEX-6p-1 insoluble   
22 18.57 12.55 ? pET15b no expression NA 
        pET28a-sumo no expression   
        pGEX-4T-1 no expression   
94 16.24 7.92 ? pET32aM no expression NA 
        pET28a-sumo no expression   
        pGEX-6p-1 no expression   
117 6.28 8.46 ? pET15b no expression NA 
        pET28a-sumo soluble   
        pGEX-4T-1 soluble   
156 31.12 5.61 ? pET15b insoluble NA 
        pET28a-sumo soluble   
        pGEX-4T-1 insoluble   
86 17.11 8.08 IE pET15b FL insoluble rabbit poly 
        pET28b insoluble   
        pET28a-sumoFL soluble   
        pGEX-6P-1 FL insoluble   
        pET15b (1-85) no expression   
        pET28a-sumo(1-85) soluble   
        pGEX-6P-1(1-85) insoluble   
        pET15b (1-105) no expression   
        pET28a-sumo(1-105) soluble   
        pGEX-6P-1(1-105) insoluble   
18 32.32 6.02 L pETDuet soluble rabbit poly 
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 75 19.96 4.5 L pET32aM(68-178) no expression rabbit poly 
        pET28a-sumo(68-178) no expression   
        pGEX-4T-1(68-178) no expression   
        pET32aM(80-178) no expression   
        pET28a-sumo(80-178) no expression   
        pGEX-4T-1(80-178) no expression   
 
Vectors: 
pET15b (Amersham Biosciences), pET28b(Novagen), pET28a-sumo(provided by Adam 
Yuan’s lab, sumo is cloned into pET28a vector between Nde I and BamH I), 
pET32aM(modified by our lab), pGEX 6P-1(Amersham Biosciences), pGEX 4T-
2(Amersham Biosciences), 
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Comptent cell preparetation buffer: 
Tfb I (per liter) 
To 950 ml of MQ H2O, add: 
CH3COOK  2.94 g 
RbCl   12.1 g 
CaCl2·2H2O  14.7 g 
MnCl2·4H2O  9.9 g 
Glycerol  150 mL 
Adjust pH to 5.8 with dilute acetic acid, add MQ H2O to 1 L and autoclave. 
 
Tfb II (per liter) 
To 950 mL of MQ H2O, add: 
MOPS   2.1 g 
CaCl2   11.1 g 
RbCl   1.21 g 
Glycerol  150 mL 
Adjust pH to 6.5 with 1 M NaOH, add MQ H2O to 1 L and autoclave. 
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